Elicio Therapeutics's total assets for Q2 2026 were $31.33M, an increase of 38.08% from the previous quarter. DE:9HA total liabilities were $23.39M for the fiscal quarter, a -3.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.